Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk ...

Mursla Bio, a Cambridge UK and Boston US leader in Extracellular Vesicle (EV) science, has received FDA approval for its lead ...

Bayer and Vividion Therapeutics to present latest research on their advancing oncology portfolio at AACR 2025 annual meeting: Berlin, Germany Wednesday, April 23, 2025, 10:00 Hrs ...

During a Community Case Forum event, Stacey Stein, MD, discussed data guiding the use of current regimens for the treatment ...

California-based Tempest Therapeutics is laying off 21 of its 26 full-time employees. The cuts come while the biotech is ...

Gerry said: “I was shocked to find out that I had liver cancer, but also relieved that it had been found early and it hadn’t ...

The week marked several FDA approvals for drugs and devices, plus data continues to show tarlatamab’s benefit in small cell lung cancer.

We have a new author in our midst. It’s Gary Hedstrom of Owatonna, who wrote the book “Small Town Minnesota Farm Boy”. The ...

New York AI startup 1Fort secures $7.5M in funding to streamline commercial insurance for small businesses with its broker-focused platform that cuts paperwork from hours to minutes.

Coherus BioSciences is now heavily focused on developing its pipeline, particularly casdozokitug and CHS-114. See why I rate ...

And that’s where CFLite comes in. CFLite is CFMoto’s new spin-off brand focused entirely on small-displacement bikes. Think ...

A leading human rights lawyer has spoken out after helping file a legal case against 10 British nationals accused of war ...